FDA NDC Directory · JSON-LD · Markdown

Novolin R

NDC 0169-1833 · HUMAN OTC DRUG · INJECTION, SOLUTION

Generic nameHuman Insulin
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA019938
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN HUMAN (100 [iU]/mL)
Marketing started19910625
Package count2

External sources

Source: openFDA. Public-domain (CC0).